These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11829712)

  • 41. [Allergy to macrolide antibiotics. Review of the literature].
    Demoly P; Benahmed S; Valembois M; Sahla H; Messaad D; Godard P; Michel FB; Bousquet J
    Presse Med; 2000 Feb; 29(6):321-6. PubMed ID: 10719452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Choosing the right macrolide antibiotic. A guide to selection.
    Charles L; Segreti J
    Drugs; 1997 Mar; 53(3):349-57. PubMed ID: 9074839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Empiric antibiotic selection criteria for respiratory infections in pediatric practice.
    Pichichero ME
    Pediatr Infect Dis J; 1997 Mar; 16(3 Suppl):S60-4. PubMed ID: 9076838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dental therapeutic indications for the newer long-acting macrolide antibiotics.
    Moore PA
    J Am Dent Assoc; 1999 Sep; 130(9):1341-3. PubMed ID: 10492541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
    Brogden RN; Peters DH
    Drugs; 1994 Oct; 48(4):599-616. PubMed ID: 7528132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotics for acute orofacial infections.
    Pallasch TJ
    J Calif Dent Assoc; 1993 Feb; 21(2):34-44. PubMed ID: 7693890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin.
    McConnell SA; Amsden GW
    Pharmacotherapy; 1999 Apr; 19(4):404-15. PubMed ID: 10212011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clindamycin, erythromycin, and the newer macrolides.
    Raebel MA; Browne BA
    Clin Podiatr Med Surg; 1992 Apr; 9(2):409-23. PubMed ID: 1586909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ketolides in the treatment of respiratory infections.
    Zhanel GG; Hoban DJ
    Expert Opin Pharmacother; 2002 Mar; 3(3):277-97. PubMed ID: 11866679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microbiologic activity of the newer macrolide antibiotics.
    McCracken GH
    Pediatr Infect Dis J; 1997 Apr; 16(4):432-7. PubMed ID: 9109155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The future role and importance of macrolides.
    Ball P
    J Hosp Infect; 1991 Sep; 19 Suppl A():47-59. PubMed ID: 1684983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
    Zhanel GG; Hartel E; Adam H; Zelenitsky S; Zhanel MA; Golden A; Schweizer F; Gorityala B; Lagacé-Wiens PR; Walkty AJ; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2016 Dec; 76(18):1737-1757. PubMed ID: 27909995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.
    Hare KM; Grimwood K; Chang AB; Chatfield MD; Valery PC; Leach AJ; Smith-Vaughan HC; Morris PS; Byrnes CA; Torzillo PJ; Cheng AC
    Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2275-85. PubMed ID: 26363637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data.
    Carbon C; Poole MD
    J Chemother; 1999 Apr; 11(2):107-18. PubMed ID: 10326741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
    Braga PC
    J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Disappearance of Streptococcus pyogenes macrolide resistance in an area of northeastern Italy: a possible link with rational long-acting macrolide consumption].
    De Rosa R; Avolio M; Stano P; Modolo ML; Camporese A
    Infez Med; 2009 Jun; 17(2):82-7. PubMed ID: 19602920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel macrolide-resistance genes, mef(C) and mph(G), carried by plasmids from Vibrio and Photobacterium isolated from sediment and seawater of a coastal aquaculture site.
    Nonaka L; Maruyama F; Suzuki S; Masuda M
    Lett Appl Microbiol; 2015 Jul; 61(1):1-6. PubMed ID: 25765542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nature nurtures the design of new semi-synthetic macrolide antibiotics.
    Fernandes P; Martens E; Pereira D
    J Antibiot (Tokyo); 2017 May; 70(5):527-533. PubMed ID: 27899792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.